Can You Have PBC With a Negative AMA Test?

Yes, you can absolutely have primary biliary cholangitis (PBC) even if your antimitochondrial antibody (AMA) test is negative ^[1]. While a positive AMA is the hallmark of the condition and is found in the vast majority of patients, roughly 5% to 10% of people with PBC will never test positive for it ^[1][2]. This is known in the medical community as AMA-negative PBC.

Getting a negative AMA result when your doctor suspects PBC can be confusing, but it does not mean your symptoms are imagined or that you have a completely different, mysterious illness.

The Same Disease, Just a Missing Marker

Researchers do not consider AMA-negative PBC to be a separate disease from AMA-positive PBC ^[3]. The underlying condition is the same: your immune system is mistakenly attacking the small bile ducts in your liver.

People with AMA-negative PBC experience the same primary symptoms, such as severe fatigue and intense itching (pruritus) ^[4]. Furthermore, your liver enzymes—specifically your alkaline phosphatase (ALP), a key indicator of bile duct irritation—will be elevated in the exact same way ^[2][4].

How is AMA-Negative PBC Diagnosed?

When your AMA is negative but your ALP is elevated, hepatologists (liver specialists) look for other specific clues in your blood. They will often test for other autoantibodies (proteins your immune system produces that mistakenly attack your own tissues). Specifically, they look for certain types of antinuclear antibodies (ANA) known as anti-Sp100 and anti-gp210, which are highly specific to PBC ^[5][6].

• Anti-Sp100 and Anti-gp210: These are specialized blood tests usually sent to a major lab. If you test positive for either of these, it strongly supports a PBC diagnosis even without a positive AMA ^[7][8].
• Liver Biopsy: If both your AMA and these alternative antibodies are negative, your doctor may recommend a liver biopsy. During a biopsy, a tiny sample of liver tissue is examined under a microscope to look for the classic bile duct damage seen in PBC ^[9].

Does a Negative AMA Change Your Treatment or Outlook?

A negative AMA does not change your treatment plan. The standard, first-line therapy for all PBC patients is Ursodeoxycholic acid (UDCA) ^[10]. UDCA helps move bile out of the liver, reducing inflammation and slowing disease progression, and it is equally effective for AMA-negative patients ^[11]. If UDCA is not fully effective, there are multiple second-line therapies available (such as obeticholic acid, fibrates, elafibranor, or seladelpar) that can be added to your regimen.

Regarding your long-term outlook, extensive research shows that overall survival rates and the likelihood of needing a liver transplant are similar whether you are AMA-positive or AMA-negative ^[4].

However, the specific alternative antibodies you have might give your doctor extra information. For example, testing positive for the anti-gp210 antibody can indicate a slightly higher risk for liver scarring or disease progression over time ^[12][13]. This is not a reason to panic—it simply means your care team will monitor your liver health more closely and may be more proactive in adjusting your medications to ensure your liver remains protected.